Siyuan Cheng, LSU Health Shreveport, Department of Biochemistry

Siyuan Cheng, PhD


BS, Biotechnology, Hunan University, 2013

PhD, Biochemistry and Molecular Biology, LSUHS, 2022

Google Scholar



RESEARCH INTEREST: Prostate cancer, Neuroendocrine prostate cancer, Bioinformatics, Big data

Current Research

CTPC: a combined transcriptome data set of human prostate cancer cell lines

CTPC website: CTPC

cover of The Prostate Feb 2023 Vol 83 No 2

Abstract: Cell lines are the most used model system in cancer research. The transcriptomic data of established prostate cancer (PCa) cell lines help researchers explore differential gene expressions across the various PCa cell lines. Through large scale datamining, we established a curated Combined Transcriptome dataset of PCa Cell lines (CTPC) which contains the transcriptomic data of 1840 samples of 9 commonly used PCa cell lines including LNCaP, LNCaP-95, LNCaP-abl, C4-2, VCaP, 22Rv1, PC3, DU145, and NCI-H660. The CTPC dataset provides an opportunity for researchers to not only compare gene expression across different PCa cell lines but also retrieve the experiment information and associate the differential gene expression data with meta data, such as gene manipulation and drug treatment information. Additionally, based on the CTPC dataset, we built a platform for users to visualize the data. It is our hope that the combined CTPC dataset and the user-friendly platform are of great service to the PCa research community.

HuPSA & MoPSA: single-cell RNAseq atlas for human and mouse prostate samples


Abstract: Androgen deprivation therapy has improved patient survival. Nevertheless, treatment resistance inevitably emerges due to the complex interplay of tumor heterogeneity and lineage plasticity. We integrated scRNAseq data from multiple studies, comprising both publicly available cohorts and data generated by our research team, and established the HuPSA (Human Prostate Single cell Atlas) and MoPSA (Mouse Prostate Single cell Atlas) datasets. Through unsupervised clustering and manual annotation, we found that both atlases consisted of previously known cell clusters including prostate adenocarcinoma (AdPCa), neuroendocrine prostate cancer (NEPCa), stromal, and immune cell populations. Our analysis also unearthed the less described populations including MMP7+ normal prostate club cells and two novel lineage plastic cancerous populations, namely Progenitor-like and KRT7. Immunohistochemical staining analysis confirmed the presence of these populations in both human and mouse PCa tissues, reinforcing their significance in PCa pathobiology. To unravel the molecular drivers of these distinct cell populations, we explored the upstream regulators of the genes enriched in these cells. Furthermore, employing HuPSA-based deconvolution, we scrutinized over one thousand human PCa bulk RNAseq samples and reclassified them into different molecular subtypes, including the newly discovered KRT7 and Progenitor-like categories. Moreover, employing supervised dimensional reduction and label transferring techniques, we projected the scRNAseq data derived from C4-2B xenograft tumors onto HuPSA. Our analysis effectively identified the C4-2B derived diverse subpopulations including NEPCa. The HuPSA & MoPSA app ( have been launched for users to visualize and quantify genes expression in both atlases at single-cell level. Similarly, we also launched the PCaAtlas app ( for users to visualize genes expression in re-classified human prostatic tissue samples. In conclusion, our study elucidates a roadmap of PCa progression, showcasing the development of heterogeneous populations and the involvement of lineage plasticity. This understanding holds promise for guiding the development of precision medicine in PCa field. Additionally, the HuPSA and MoPSA provide invaluable blueprints for analyzing and interpreting user-generated PCa single-cell RNAseq data.



PCaAtlas: Bulk RNAseq atlas for human PCa samples deconvoluted by HuPSA

PCaAtlas website: